|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating activities | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Depreciation and amortization | |||||
| Equity-based compensation | |||||
| Change in fair value of warrants | |||||
| Debt extinguishment loss | |||||
| Issuance of common warrants | |||||
| Change in fair value of derivative liability | |||||
| Change in fair value of asset purchase agreement liability | |||||
| Realized and unrealized gain on marketable securities | |||||
| Realized and unrealized gain on short term investments | |||||
| Equity method investment (gain)loss | |||||
| Asset retirement obligation accretion | |||||
| Amortization of debt discount | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Other current assets | |||||
| Other assets | |||||
| Accounts payable | |||||
| Deferred revenue | |||||
| Accrued expenses and other liabilities | |||||
| Operating lease right-of-use assets and liabilities | |||||
| Net cash used in operating activities | |||||
| Investing activities | |||||
| Purchases of network assets, property, and equipment | |||||
| Purchase of equity method investment | |||||
| Purchase of internal use software | |||||
| Purchase of marketable securities | |||||
| Sale and maturity of marketable securities | |||||
| Payment for asset purchase agreement liability | |||||
| Net cash used in investing activities | |||||
| Financing activities | |||||
| Proceeds from debt | |||||
| Proceeds from 2028 senior convertible notes | |||||
| Repayment of 2026 senior secured notes | |||||
| Payments towards debt issuance cost | |||||
| Payments towards debt | |||||
| Proceeds from exercise of common stock options | |||||
| Proceeds from exercise of common warrants | |||||
| Redemption of non-controlling interests | |||||
| Net cash provided by financing activities | |||||
| Effect of exchange rates on cash and cash equivalents | |||||
| Net increase (decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of period | |||||
| Cash and cash equivalents at end of period | |||||
| Supplemental disclosures | |||||
| Capital expenditure included in Accrued expenses and other current liabilities | |||||
| Issuance of shares for asset purchase agreement | |||||
| Issuance of warrants | |||||
| Interest paid in cash | |||||
| Reclassification of warrant liability to common stock warrants | |||||
| Income taxes paid, net | |||||
| Interest paid in shares | |||||
Loading...